Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 7;76(3):359-370.
doi: 10.1016/j.molcel.2019.09.030. Epub 2019 Oct 24.

Mechanisms Controlling PD-L1 Expression in Cancer

Jong-Ho Cha  1 , Li-Chuan Chan  2 , Chia-Wei Li  2 , Jennifer L Hsu  2 , Mien-Chie Hung  3
Affiliations
Review

Mechanisms Controlling PD-L1 Expression in Cancer

Jong-Ho Cha et al. Mol Cell. .

Abstract

The engagement of programmed cell death protein 1 (PD-1; encoded by the PDCD1 gene) receptor expressed on activated T cells and its ligand, programmed death-ligand 1 (PD-L1; encoded by the CD274 gene), is a major co-inhibitory checkpoint signaling that controls T cell activities. Various types of cancers express high levels of PD-L1 and exploit PD-L1/PD-1 signaling to evade T cell immunity. Blocking the PD-L1/PD-1 pathway has consistently shown remarkable anti-tumor effects in patients with advanced cancers and is recognized as the gold standard for developing new immune checkpoint blockade (ICB) and combination therapies. However, the response rates of anti-PD-L1 have been limited in several solid tumors. Therefore, furthering our understanding of the regulatory mechanisms of PD-L1 can bring substantial benefits to patients with cancer by improving the efficacy of current PD-L1/PD-1 blockade or other ICBs. In this review, we provide current knowledge of PD-L1 regulatory mechanisms at the transcriptional, posttranscriptional, post-translational, and extracellular levels, and discuss the implications of these findings in cancer diagnosis and immunotherapy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. The regulatory mechanism of PD-L1 expression.
The precise and complex regulation of PD-L1 expression includes genomic alteration, transcriptional regulation, post-transcriptional and post-translational modifications, and exosomal transport. Me: methylation, AC: acetylation
Figure 2.
Figure 2.. Post-translational modifications (PTM) of PD-L1.
After translation, the activity and stability of PD-L1 are regulated by various PTM. Glycosylation and palmitoylation are essential to maintain the stability of PD-L1. In addition, glycosylation affects the binding between PD-L1 and PD-1. In contrast, poly-ubiquitination is a negative regulator that induces PD-L1 degradation. Phosphorylation regulates PD-L1 level through cross-talk with the glycosylation and poly-ubiquitination.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Akbay EA, Koyama S, Carretero J, Altabef A, Tchaicha JH, Christensen CL, Mikse OR, Cherniack AD, Beauchamp EM, Pugh TJ, et al. (2013). Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors. Cancer Discov 3, 1355–1363. - PMC - PubMed
    1. Atefi M, Avramis E, Lassen A, Wong DJ, Robert L, Foulad D, Cerniglia M, Titz B, Chodon T, Graeber TG, et al. (2014). Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma. Clin Cancer Res 20, 3446–3457. - PMC - PubMed
    1. Barsoum IB, Smallwood CA, Siemens DR, and Graham CH (2014). A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res 74, 665–674. - PubMed
    1. Breitling J, and Aebi M (2013). N-linked protein glycosylation in the endoplasmic reticulum. Cold Spring Harb Perspect Biol 5, a013359. - PMC - PubMed
    1. Burr ML, Sparbier CE, Chan YC, Williamson JC, Woods K, Beavis PA, Lam EYN, Henderson MA, Bell CC, Stolzenburg S, et al. (2017). CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature 549, 101–105. - PMC - PubMed

Publication types

MeSH terms